Cemiplimab (Ingredient)

Drugbank ID: DB14707

The information below refers to products available in the United States that contain cemiplimab.

Products containing cemiplimab

cemiplimab systemic

Brand name: Libtayo
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Cemiplimab systemic is used in the treatment of:

• Basal Cell Carcinoma
• Non Small Cell Lung Cancer
• Squamous Cell Carcinoma

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer